|dcterms.references||1 Nino F. United Nations Sustainable Development Goals. UNDP.
http://www.undp.org/content/undp/en/home/sustainabledevelopment-goals.html (accessed March 10, 2017).
2 Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national
incidence, prevalence, and years lived with disability for 328 diseases
and injuries for 195 countries, 1990–2016: a systematic analysis for the
Global Burden of Disease Study 2016. Lancet 2017; 390: 1211–59.
3 Fullman N, Barber RM, Abajobir AA, et al. Measuring progress
and projecting attainment on the basis of past trends of the
health-related Sustainable Development Goals in 188 countries:
an analysis from the Global Burden of Disease Study 2016.
Lancet 2017; 390: 1423–59.
4 Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of
overweight and obesity in 195 countries over 25 years.
N Engl J Med 2017; 377: 13–27.
5 Sajedinejad S, Majdzadeh R, Vedadhir A, Tabatabaei MG,
Mohammad K. Maternal mortality: a cross-sectional study in global
health. Glob Health 2015; 11: 4.
6 Say L, Chou D, Gemmill A, et al. Global causes of maternal death:
a WHO systematic analysis. Lancet Glob Health 2014; 2: e323–33.
7 Kassebaum NJ, Lopez AD, Murray CJL, Lozano R. A comparison of
maternal mortality estimates from GBD 2013 and WHO.
Lancet 2014; 384: 2209–10.
8 Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, et al.
Global, regional, and national levels and causes of maternal
mortality during 1990–2013: a systematic analysis for the Global
Burden of Disease Study 2013. Lancet 2014; 384: 980–1004.
9 Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for
181 countries, 1980–2008: a systematic analysis of progress towards
Millennium Development Goal 5. Lancet 2010; 375: 1609–23.
10 Ginsburg O, Bray F, Coleman MP, et al. The global burden of
women’s cancers: a grand challenge in global health. Lancet 2017;
11 Bruni L, Diaz M, Barrionuevo-Rosas L, et al. Global estimates of
human papillomavirus vaccination coverage by region and
income level: a pooled analysis. Lancet Glob Health 2016;
12 Ginsburg OM, Love RR. Breast cancer: a neglected disease for the
majority of affected women worldwide. Breast J 2011; 17: 289–95.
13 Denslow SA, Rositch AF, Firnhaber C, Ting J, Smith JS.
Incidence and progression of cervical lesions in women with HIV:
a systematic global review. Int J STD AIDS 2014; 25: 163–77.
14 Adler AJ, Ronsmans C, Calvert C, Filippi V. Estimating the
prevalence of obstetric fistula: a systematic review and meta-analysis.
BMC Pregnancy Childbirth 2013; 13: 246.
15 Kelly J. Vesico-vaginal fistula. The burden of maternal ill-health.
Safe Mother 1999; 5: 7.
16 Ahmed S, Tunçalp Ö. Burden of obstetric fistula: from
measurement to action. Lancet Glob Health 2015; 3: e243–44
17 Wall LL. Obstetric fistula is a “neglected tropical disease”.
PLoS Negl Trop Dis 2012; 6: e1769.
18 Higashi H, Barendregt JJ, Kassebaum NJ, Weiser TG, Bickler SW,
Vos T. Surgically avertable burden of obstetric conditions in low- and
middle-income regions: a modelled analysis.
BJOG Int J Obstet Gynaecol 2014; 122: 228–36.
19 GBD 2017 Mortality Collaborators. Global, regional, and national
age-specific mortality and life expectancy, 1950–2017: a systematic
analysis for the Global Burden of Disease Study 2017. Lancet 2018;
20 Stevens GA, Alkema L, Black RE, et al. Guidelines for accurate and
transparent health estimates reporting: the GATHER statement.
Lancet 2016; 388: e19–23.
21 United Nations Population Division. Department of Economic and
Social Affairs. Population. https://www.un.org/development/desa/
en/key-issues/population.html (accessed May 6, 2017).
22 US Census Bureau. International Data Base (IDB). https://www.
html (accessed May 6, 2018).
23 Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the
Global Burden of Disease 2013 study. Lancet Glob Health 2015;
24 GBD 2017 Population and Fertility Collaborators. Population and
fertility by age and sex for 195 countries and territories 1950–2017:
a systematic analysis for the Global Burden of Disease 2017.
Lancet 2018; 392: 1995–2051.
25 GBD 2017 Cause of Death Collaborators. Global, regional, and
national age-specific and sex-specific mortality for 282 causes of death
in 195 countries and territories, 1980–2017: a systematic analysis for
the Global Burden of Disease Study 2017. Lancet 2018; 392: 1736–88.
26 Mckee S. Rethinking development and health: findings from the
Global Burden of Disease Study. Seattle, WA: Institute for Health
Metrics and Evaluation, 2016.
27 The Lancet. The global HIV/AIDS epidemic—progress and
challenges. Lancet 2017; 390: 333.
28 Locarnini S, Hatzakis A, Chen D-S, Lok A. Strategies to control
hepatitis B: Public policy, epidemiology, vaccine and drugs.
J Hepatol 2015; 62: S76–86.
29 Razavi H, ElKhoury AC, Elbasha E, et al. Chronic hepatitis C virus
(HCV) disease burden and cost in the United States. Hepatology 2012;
30 Hill A, Cooke G. Hepatitis C can be cured globally, but at what cost?
Science 2014; 345: 141–42.
31 Kamal-Yanni M. Hepatitis C drug affordability. Lancet Glob Health
2015; 3: e73–74.
32 Attard SM, Herring AH, Zhang B, Du S, Popkin BM,
Gordon-larsen P. Associations between age, cohort,
and urbanization with Sbp and Dbp in China: a population-based
study across 18 years. J Hypertens 2015; 33: 948–56.
33 Song L, Shen L, Li H, et al. Height and prevalence of hypertension in
a middle-aged and older Chinese population. Sci Rep 2016; 6: 39480.
34 Muntner P, Gu D, Wu X, et al. Factors associated with hypertension
awareness, treatment, and control in a representative sample of the
chinese population. Hypertension 2004; 43: 578–85.
35 Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in US
deaths from coronary disease, 1980–2000. N Engl J Med 2007;
36 Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic:
shaped by global drivers and local environments. Lancet 2011;
37 Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary
prevention and risk reduction therapy for patients with coronary
and other atherosclerotic vascular disease: 2011 update: a guideline
from the American Heart Association and American College of
Cardiology Foundation. Circulation 2011; 124: 2458–73.
38 Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline
on lifestyle management to reduce cardiovascular risk: a report
of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines. Circulation 2014; 129: S76–99.
39 Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA
guideline on the treatment of blood cholesterol to reduce
atherosclerotic cardiovascular risk in adults: a report of the
American College of Cardiology/American Heart Association Task
Force on Practice Guidelines. Circulation 2014; 129: S1–45.
40 Perk J, De Backer G, Gohlke H, et al. European Guidelines on
cardiovascular disease prevention in clinical practice (version 2012).
The Fifth Joint Task Force of the European Society of Cardiology
and Other Societies on Cardiovascular Disease Prevention in
Clinical Practice (constituted by representatives of nine societies
and by invited experts). Eur Heart J 2012; 33: 1635–701.
41 Daya MR, Schmicker RH, Zive DM, et al. Out-of-hospital cardiac
arrest survival improving over time: results from the Resuscitation
Outcomes Consortium (ROC). Resuscitation 2015; 91: 108.
42 Girotra S, Nallamothu BK, Spertus JA, Li Y, Krumholz HM,
Chan PS. Trends in survival after in-hospital cardiac arrest.
N Engl J Med 2012; 367: 1912.
43 Berger S. Survival from out-of-hospital cardiac arrest:
are we beginning to see progress? J Am Heart Assoc 2017; 6: e007469.
44 American College of Cardiology. Despite overall in-hospital cardiac
arrest survival improvement, lower survival on nights, weekends
May 7, 2018).
45 Malhotra A, Rakhit R. Improving the UK’s performance on survival
after cardiac arrest. BMJ 2013; 347: f4800.
46 Sasson C, Rogers MAM, Dahl J, Kellermann AL. Predictors of
survival from out-of-hospital cardiac arrest: a systematic review and
meta-snalysis. Circ Cardiovasc Qual Outcomes 2010; 3: 63–81.
47 Mora S, Wenger NK, DeMicco DA, et al. Determinants of residual
risk in secondary prevention patients treated with high- versus
low-dose statin therapy clinical perspective: the treating to new
targets (TNT) study. Circulation 2012; 125: 1979–87.
48 Critchley JA, Capewell S. Mortality risk reduction associated with
smoking cessation in patients with coronary heart disease:
a systematic review. JAMA 2003; 290: 86.
49 Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL.
Psychologic effects of continuous and nocturnal oxygen therapy in
hypoxemic chronic obstructive pulmonary disease.
Arch Intern Med 1983; 143: 1941–47.
50 Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J.
Long-term oxygen therapy improves health-related quality of life.
Respir Med 2004; 98: 285–93.
51 Clini E, Vitacca M, Foglio K, Simoni P, Ambrosino N.
Long-term home care programmes may reduce hospital
admissions in COPD with chronic hypercapnia. Eur Respir J 1996;
52 Tanni SE, Vale SA, Lopes PS, Guiotoko MM, Godoy I, Godoy I.
Influence of the oxygen delivery system on the quality of life of
patients with chronic hypoxemia. J Bras Pneumol 2007; 33: 161–67.
53 Ringbaek TJ, Viskum K, Lange P. Does long-term oxygen therapy
reduce hospitalisation in hypoxaemic chronic obstructive
pulmonary disease? Eur Respir J 2002; 20: 38–42.
54 Weitzenblum E, Oswald M, Apprill M, Ratomaharo J, Kessler R.
Evolution of physiological variables in patients with chronic
obstructive pulmonary disease before and during long-term oxygen
therapy. Respir Int Rev Thorac Dis 1991; 58: 126–31.
55 Poole PJ, Chacko E, Wood-Baker RWB, Cates CJ. Influenza vaccine
for patients with chronic obstructive pulmonary disease.
Cochrane Database Syst Rev 2006; 1: CD002733.
56 Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U,
Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in
patients with COPD and the effectiveness of influenza vaccination:
a randomized controlled study. Chest 2004; 125: 2011–20.
57 Nichol KL, Baken L, Nelson A. Relation between influenza
vaccination and outpatient visits, hospitalization, and mortality in
elderly persons with chronic lung disease. Ann Intern Med 1999;
58 Xu J, Zhang Y, Qiu C, Cheng F. Global and regional economic costs
of dementia: a systematic review. Lancet 2017; 390: S47.
59 Xu J, Wang J, Wimo A, Fratiglioni L, Qiu C. The economic burden
of dementia in China, 1990–2030: implications for health policy.
Bull World Health Organ 2017; 95: 18–26.
60 Alzheimer’s Disease International. World Alzheimer Report 2015
reveals global cost of dementia set to reach US $1 trillion by 2018.
(accessed May 7, 2018).
61 Wimo A, Winblad B. The economic burden of Alzheimer’s disease
and dementia. In: Alzheimer’s disease. Totowa, NJ: Humana Press,
62 Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM.
Monetary costs of dementia in the United States. N Engl J Med 2013;
63 Walsh J. Dementia UK report. United Kingdom: Alzheimer’s
Society, 2015. https://www.alzheimers.org.uk/info/20025/policy_
and_influencing/251/dementia_uk (accessed May 7, 2018).
64 Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in
autoimmune disease from a pathological perspective. Am J Pathol
2008; 173: 600–09.
65 Rubtsova K, Marrack P, Rubtsov AV. Sexual dimorphism in
autoimmunity. J Clin Invest 2015; 125: 2187–93.
66 Kassebaum NJ, Barber RM, Bhutta ZA, et al. Global, regional,
and national levels of maternal mortality, 1990–2015: a systematic
analysis for the Global Burden of Disease Study 2015. Lancet 2016;
67 Kinney MV, Boldosser-Boesch A, McCallon B. Quality, equity,
and dignity for women and babies. Lancet 2016; 388: 2066–68.
68 Graham G. Acute coronary syndromes in women: recent treatment
trends and outcomes. Clin Med Insights Cardiol 2016; 10: 1–10.
69 Lai M-C, Lombardo MV, Ruigrok ANV, et al. Cognition in males and
females with autism: similarities and differences. PLoS One 2012;
70 Kopp S, Gillberg C. The autism spectrum screening questionnaire
(ASSQ)-revised extended version (ASSQ-REV): an instrument for
better capturing the autism phenotype in girls? A preliminary study
involving 191 clinical cases and community controls. Res Dev Disabil
2011; 32: 2875–88.
71 Lai M-C, Lombardo MV, Pasco G, et al. A behavioral comparison of
male and female adults with high functioning autism spectrum
conditions. PLoS One 2011; 6: e20835.
72 The World Bank. Countries commit to strong action on human
capital to drive economic growth. Oct 20, 2017. http://www.
May 7, 2018).
73 The World Bank. Human capital: the greatest asset of economies on
the rise. April 3, 2017. http://www.worldbank.org/en/news/
opinion/2017/04/03/human-capital-the-greatest-asset-of-economieson-the-rise (accessed May 7, 2018).
74 Fricke T, Holden B, Wilson D, et al. Global cost of correcting vision
impairment from uncorrected refractive error.
Bull World Health Organ 2012; 90: 728–38.
75 Frick KD, Joy SM, Wilson DA, Naidoo KS, Holden BA. The global
burden of potential productivity loss from uncorrected presbyopia.
Ophthalmology 2015; 122: 1706–10.
76 Crews JE, DPA, Chou C-F, Stevens JA, Saaddine JB. Falls among
persons aged ≥65 years with and without severe vision
impairment—United States, 2014. MMWR Morb Mortal Wkly Rep
2016; 65: 433–37.
77 Lord SR. Visual risk factors for falls in older people. Age Ageing 2006;
35 (suppl 2): 42–45.
78 MAL-ED Network Investigators. The MAL-ED study: a multinational
and multidisciplinary approach to understand the relationship
between enteric pathogens, malnutrition, guxphysiology, physical
growth, cognitive development, and immune responses in infants
and children up to 2 years of age in resource-poor environments.
Clin Infect Dis 2014; 59 (suppl 4): S193–206.
79 GEMS: Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and
aetiology of diarrhoeal disease in infants and young children in
developing countries (the Global Enteric Multicenter Study, GEMS):
a prospective, case-control study. Lancet 2013; 382: 209–22.
80 Platts-Mills J, Liu J, Rogawski E, et al. Aetiology, burden and clinical
characteristics of diarrhoea in children in low-resource settings
using quantitative molecular diagnostics: results from the MAL-ED
cohort study. Lancet Glob Health (in press).
81 Walker CLF, Rudan I, Liu L, et al. Global burden of childhood
pneumonia and diarrhoea. Lancet 2013; 381: 1405–16.
82 Rudan I, O’Brien KL, Nair H, et al. Epidemiology and etiology of
childhood pneumonia in 2010: estimates of incidence, severe
morbidity, mortality, underlying risk factors and causative pathogens
for 192 countries. J Glob Health 2013; 3: 010401.
83 Stover J, Brown T, Puckett R, Peerapatanapokin W. Updates to the
Spectrum/Estimations and Projections Package model for estimating
trends and current values for key HIV indicators. AIDS 2017; 31: S5.
84 Mahy M, Penazzato, Martina M, Ciaranello A, et al. Improving
estimates of children living with HIV from the Spectrum AIDS
Impact Model. AIDS 2017; 31: S13–22.
85 UNAIDS. Methods for deriving UNAIDS estimates. Geneva,
Switzerland: UNAIDS, 2016.
86 Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD
and NASH: trends, predictions, risk factors and prevention.
Nat Rev Gastroenterol Hepatol 2018; 15: 11–20.
87 American Psychiatric Association. Diagnostic and statistical manual
of mental disorders, 5th edn. Arlington, VA: American Psychiatric
88 WHO. Falls. Jan 16, 2018. http://www.who.int/news-room/factsheets/detail/falls (accessed May 7, 2018).
89 WHO. Road traffic injuries. Jan 16, 2018. http://www.who.int/
violence_injury_prevention/road_traffic/en/ (accessed May 7, 2018).
90 WHO. Burns. http://www.who.int/violence_injury_prevention/
burns/en/ (accessed May 7, 2018).
91 Makary MA, Daniel M. Medical error—the third leading cause of
death in the US. BMJ 2016; 353: i2139.
92 Feigin VL, Abajobir AA, Abate KH, et al. Global, regional,
and national burden of neurological disorders during 1990–2015:
a systematic analysis for the Global Burden of Disease Study 2015.
Lancet Neurol 2017; 16: 877–97.
93 Research Data Assistance Center. Medicare current beneficiary
survey (MCBS). https://www.resdac.org/cms-data/file-family/
Medicare-Current-Beneficiary-Survey-MCBS (accessed May 7, 2018).||spa